{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360016865892825472.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/j.ejmech.2011.09.006"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0223523411006453?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0223523411006453?httpAccept=text/plain"}}],"dc:title":[{"@value":"Synthesis and characterization of novel bis(carboxylato)dichloridobis(ethylamine)platinum(IV) complexes with higher cytotoxicity than cisplatin"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380016865892825478","@type":"Researcher","foaf:name":[{"@value":"Hristo Varbanov"}]},{"@id":"https://cir.nii.ac.jp/crid/1380016865892825476","@type":"Researcher","foaf:name":[{"@value":"Seied M. Valiahdi"}]},{"@id":"https://cir.nii.ac.jp/crid/1380016865892825474","@type":"Researcher","foaf:name":[{"@value":"Anton A. Legin"}]},{"@id":"https://cir.nii.ac.jp/crid/1380016865892825472","@type":"Researcher","foaf:name":[{"@value":"Michael A. Jakupec"}]},{"@id":"https://cir.nii.ac.jp/crid/1380016865892825473","@type":"Researcher","foaf:name":[{"@value":"Alexander Roller"}]},{"@id":"https://cir.nii.ac.jp/crid/1380016865892825477","@type":"Researcher","foaf:name":[{"@value":"Mathea S. Galanski"}]},{"@id":"https://cir.nii.ac.jp/crid/1380016865892825475","@type":"Researcher","foaf:name":[{"@value":"Bernhard K. Keppler"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"02235234"}],"prism:publicationName":[{"@value":"European Journal of Medicinal Chemistry"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2011-11","prism:volume":"46","prism:number":"11","prism:startingPage":"5456","prism:endingPage":"5464"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/","https://www.elsevier.com/legal/tdmrep-license","http://creativecommons.org/licenses/by-nc-nd/3.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0223523411006453?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0223523411006453?httpAccept=text/plain"}],"createdAt":"2011-09-10","modifiedAt":"2025-10-01","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/2050870367085358720","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Dual-action Pt(Ⅳ) prodrugs and targeted delivery in metal-organic frameworks : overcoming cisplatin resistance and improving anticancer activity"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.ejmech.2011.09.006"},{"@type":"CROSSREF","@value":"10.1246/bcsj.20220218_references_DOI_KNOtRQ5d97QAitdVPUJTFq5lsgm"}]}